- Conditions
- Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
- Locations
-
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
- University of Iowa Iowa City, Iowa, United States
Clinical trial condition
Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
181 public trials
74 recruiting studies
Pancreatic Ductal Adenocarcinoma trial results
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +26 more
- Locations
-
- Uni of Alabama at Birmingham Birmingham, Alabama, United States
- University of California LA Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- Mayo Clinic Jacksonville Jacksonville, Florida, United States
NCT06710756
- Conditions
- Adenoma, Adnexal Diseases, Colonic Diseases, +39 more
- Locations
-
- University of Miami Miami, Florida, United States
- Biogenix Miami, Florida, United States
- University of Kansas Kansas City, Kansas, United States
- University of Kentucky Lexington, Kentucky, United States
NCT06428409
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
- Locations
-
- UCLA ( Site 0317) Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus ( Site 0299) Aurora, Colorado, United States
- University of Colorado Anschutz Medical Campus ( Site 0325) Aurora, Colorado, United States
- University of Colorado Anschutz Medical Campus ( Site 0326) Aurora, Colorado, United States
Recruiting
Durvalumab and Oleclumab in Resectable PDAC
NCT06060405
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Recruiting
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
NCT07432633
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
NCT05346536
- Conditions
- Circulating Tumor Cell, Digestive System Diseases, Digestive System Neoplasms, +13 more
- Locations
-
- CHU Montpellier Montpellier, France
NCT06586515
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California, Los Angeles (UCLA) Santa Monica, California, United States
- Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
- Sibley Memorial Hospital Washington D.C., District of Columbia, United States
NCT07219238
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Colonic Diseases, +32 more
- Locations
-
- BAMF Health Grand Rapids, Michigan, United States
- Karolinska Universitetssjukhuset Stockholm, Sweden
NCT07261631
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +30 more
- Locations
-
- Novartis Investigative Site Montreal, Quebec, Canada
- Novartis Investigative Site Odense C, Denmark
- Novartis Investigative Site Vandœuvre-lès-Nancy, France
- Novartis Investigative Site Essen, Germany